financetom
Business
financetom
/
Business
/
Thermo Fisher nears $10 billion takeover of drug trial software maker Clario, FT reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Thermo Fisher nears $10 billion takeover of drug trial software maker Clario, FT reports
Oct 28, 2025 7:03 PM

(Reuters) -Life sciences group Thermo Fisher is nearing an all-cash takeover of drug trial software maker Clario in a deal that could value the healthcare technology group at approximately $10 billion, the Financial Times reported on Tuesday.

Reuters could not immediately verify the report.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Form 8.3
Form 8.3
Nov 13, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: BALYASNY ASSET MANAGEMENT L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Israeli identity and security solutions firm SuperCom's Q3 revenue beats expectations
Israeli identity and security solutions firm SuperCom's Q3 revenue beats expectations
Nov 13, 2025
Overview * SuperCom ( SPCB ) Q3 revenue beats analyst expectations, despite a year-over-year decline * Company secured over 30 new EM contracts in the U.S. since mid-2024 Outlook * SuperCom ( SPCB ) did not provide specific financial guidance for future quarters or the full year Result Drivers * GROSS MARGIN EXPANSION - Co achieved higher gross margins, expanding...
Metsera shareholders vote for up to $10 billion acquisition by Pfizer
Metsera shareholders vote for up to $10 billion acquisition by Pfizer
Nov 13, 2025
Nov 13 (Reuters) - Metsera ( MTSR ) shareholders on Thursday approved Pfizer's ( PFE ) takeover offer worth up to $10 billion, as per preliminary count, allowing the U.S. pharmaceutical giant to gain a foothold in the lucrative obesity treatment market after a fierce bidding war with Wegovy-maker Novo Nordisk. The approval paves the way for Pfizer ( PFE...
US judge denies motions to disqualify officers, advisors involved in Citgo auction
US judge denies motions to disqualify officers, advisors involved in Citgo auction
Nov 13, 2025
HOUSTON (Reuters) -A U.S. judge has denied motions filed by Venezuela and miner Gold Reserve ( GDRZF ) to disqualify him, a court officer and two advising firms overseeing an auction of shares in the parent of U.S. refiner Citgo Petroleum, according to a court filing on Thursday. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved